Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Change in Taxes (2020 - 2023)

Apyx Medical posted quarterly Change in Taxes of -$7.8 million for Q3 2023, down 7891.75% year-on-year from $99489.8 in Q3 2022, and down 3844.93% on a QoQ basis from $207000.0 in Q1 2023.

Apyx Medical (APYX) has 4 years of Change in Taxes data on file, last reported at -$7.8 million in Q3 2023.

  • For the quarter ending Q3 2023, Change in Taxes fell 7891.75% year-over-year to -$7.8 million; the trailing twelve-month figure through Jun 2024 stood at -$7.8 million (down 7147.27% YoY), and the FY2023 full-year result was -$7.5 million, down 7678.35% from the prior year.
  • Change in Taxes for Q3 2023 stood at -$7.8 million, down from $207000.0 in the prior quarter.
  • Across five years, Change in Taxes topped out at $4.6 million in Q1 2020 and bottomed at -$7.8 million in Q3 2023.
  • The 4-year median for Change in Taxes is $311500.0 (2020), against an average of -$53250.0.
  • The widest annual swing landed in 2021, when Change in Taxes sank 102.88%; it then sank 7891.75% in 2023.
  • A 4-year view of Change in Taxes shows it stood at $416000.0 in 2020, then tumbled by 102.88% to -$12000.0 in 2021, then plunged by 708.33% to -$97000.0 in 2022, then tumbled by 7891.75% to -$7.8 million in 2023.
  • The last three Change in Taxes figures came in at -$7.8 million (Q3 2023), $207000.0 (Q1 2023), and -$97000.0 (Q3 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Taxes (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 42.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 41.90 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Apyx Medical 174.53 Mn 143.65 Mn 7.93 Mn -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2023 -7.75 Mn
Sep 30, 2023 -7.75 Mn
Mar 31, 2023 207,000.00
Mar 31, 2023 207,000.00
Sep 30, 2022 -97,000.00
Sep 30, 2022 -97,000.00
Dec 31, 2021 -12,000.00
Dec 31, 2021 -12,000.00
Dec 31, 2020 416,000.00
Dec 31, 2020 416,000.00
Sep 30, 2020 795,000.00
Sep 30, 2020 795,000.00
Jun 30, 2020 1.38 Mn
Jun 30, 2020 1.38 Mn
Mar 31, 2020 4.64 Mn
Mar 31, 2020 4.64 Mn